Prefabricated CAD CAM Allogeneic Ring Blocks in the Anterior Maxilla With Immediate Implantation
NCT ID: NCT07163351
Last Updated: 2025-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2024-01-01
2025-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vertical and Horizontal Alveolar Ridge Augmentation Using Autogenous Onlay Blocks Combined With Guided Bone Regeneration Using Native Collagen Membrane in Atrophic Anterior Maxilla.
NCT03895060
Horizontal Anterior Maxillary Ridge Augmentation Using Autogenous Ring Block Grafts Combined With Particulate Xenogeneic Bone Versus Biphasic Beta-tri-calcium Phosphate Sulphate EthOss Graft: A Clinical Study
NCT07212985
Ridge Augmentation With Simultaneous Implant Placement Using Bone Blocks With Autogenous Tooth Graft
NCT05407363
Computer Guided Versus Conventional Augmentation Using Bone Ring
NCT03049137
Reconstruction of Deficient Atrophic Ridges Using Guide Bone Regeneration Technique
NCT06746935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
These challenges have driven the adoption of allogeneic bone blocks, particularly those fabricated using computeraided design/computer-aided manufacturing (CAD/CAM) technology, which offer precise anatomical adaptation, reduced surgical time, and minimized complications compared to manual grafting techniques
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Patients presented with anterior maxillary alveolar bone defects resulting from previous implant failure
CAD/CAM allogenic bone block
CAD/CAM allogenic bone block augmentation with immediate non-functional implant loading
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CAD/CAM allogenic bone block
CAD/CAM allogenic bone block augmentation with immediate non-functional implant loading
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both sexes.
* Patients presenting with anterior maxillary alveolar bone defects resulting from previous implant failure.
* Systemically healthy individuals, classified as American Society of Anesthesiologists (ASA) physical status I or II.
* Participants were either non-smokers or light smokers consuming fewer than 10 cigarettes per day.
Exclusion Criteria
* Pregnant or breastfeeding at the time of recruitment.
* Individuals with a history of head or neck radiation therapy.
* Cases in which insufficient bone volume for implant placement persisted following augmentation.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Omar Elboraey Elbal
Assistant Professor of Oral Medicine, Periodontology, Oral Diagnosis and Oral Radiology Department, Faculty of Dentistry, Tanta, University, Tanta, Egypt.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AUAREC20240001-7
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.